- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02374580
Partnership and Dignity: a Mixed-methods Survey on Supporting and Retaining Uganda's Village Health Teams
Studieöversikt
Status
Betingelser
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
District of Columbia
-
Washington, District of Columbia, Förenta staterna, 20037
- The George Washington University School of Medicine and Health Sciences
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
VHT subjects must have been actively working as a VHT member for at least 6 months. Stakeholders, that is, program managers, health administrators and policy makers, must be involved in managing, administrating, or guiding policy for VHT programs as part of their official job description. These persons must also have been acting in those roles for at least 6 months. All study subjects will be 18 years of age or older. All study subjects will be literate and able to be informed to give or withhold consent of participation.
Exclusion Criteria:
There will be no exclusion or inclusion based on gender, race, tribal or ethnic affiliation, religion, or health status.
Studieplan
Hur är studien utformad?
Designdetaljer
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Predicted longevity related to support sufficiency
Tidsram: Up to 5 months
|
This outcome will be measured by asking VHTs to rate aspects of their current support.
We will follow up those questions by asking how long they expect to be able to continue in their position as VHTs.
The two results will be evaluated for possible trends connecting sufficiency of existing support with predicted longevity.
|
Up to 5 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Predicted longevity of minimum 10 years if current support does not increase
Tidsram: Up to 5 months
|
This outcome will be measured by asking the VHTs if they predict being able to continue in their positions for at least 10 more years if their current support does not increase.
|
Up to 5 months
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: William S Schroth, MD MPH, George Washington University School of Medicine and Health Sciences
Publikationer och användbara länkar
Allmänna publikationer
- Okello D, Floyd K, Adatu F, Odeke R, Gargioni G. Cost and cost-effectiveness of community-based care for tuberculosis patients in rural Uganda. Int J Tuberc Lung Dis. 2003 Sep;7(9 Suppl 1):S72-9.
- Ministry of Health, Uganda, Education and Promotion Division. Village health team strategy and operational guidelines. 2010.
- Brenner JL, Kabakyenga J, Kyomuhangi T, Wotton KA, Pim C, Ntaro M, Bagenda FN, Gad NR, Godel J, Kayizzi J, McMillan D, Mulogo E, Nettel-Aguirre A, Singhal N. Can volunteer community health workers decrease child morbidity and mortality in southwestern Uganda? An impact evaluation. PLoS One. 2011;6(12):e27997. doi: 10.1371/journal.pone.0027997. Epub 2011 Dec 14.
- Kalyango JN, Rutebemberwa E, Alfven T, Ssali S, Peterson S, Karamagi C. Performance of community health workers under integrated community case management of childhood illnesses in eastern Uganda. Malar J. 2012 Aug 20;11:282. doi: 10.1186/1475-2875-11-282.
- Kayemba Nalwadda C, Guwatudde D, Waiswa P, Kiguli J, Namazzi G, Namutumba S, Tomson G, Peterson S. Community health workers - a resource for identification and referral of sick newborns in rural Uganda. Trop Med Int Health. 2013 Jul;18(7):898-906. doi: 10.1111/tmi.12106. Epub 2013 Apr 2.
- Ministry of Health Uganda. Annual Health Sector Performance Report: Financial Year 2012/2013. 2013.
- Ministry of Health Uganda. The second national health policy. 2010.
- Perry, H, et al. How effective are community health workers? an overview of current evidence with recommendations for strengthening community health worker programs to accelerate progress in achieving the health-related millennium development goals. Johns Hopkins University Bloomberg School of Public Health. 2012.
- Lehmann U., Sanders D. Community health workers: what do we know about them? The state of the evidence on programmes, activities, costs and impact on health outcomes of using community health workers. (2007) Geneva: World Health Organization. Available at: <http://www.who.int/hrh/documents/community_health_ workers.pdf>
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- VHT_041406
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Lunginflammation
-
National Institute of Allergy and Infectious Diseases...AvslutadHIV-infektioner | Pneumoni, Pneumocystis CariniiFörenta staterna
-
Glaxo WellcomeAvslutadHIV-infektioner | Pneumoni, Pneumocystis CariniiFörenta staterna
-
National Institute of Allergy and Infectious Diseases...AvslutadHIV-infektioner | Pneumoni, Pneumocystis CariniiFörenta staterna, Tanzania
-
National Institute of Allergy and Infectious Diseases...Jacobus Pharmaceutical; Glaxo WellcomeAvslutadHIV-infektioner | Pneumoni, Pneumocystis CariniiFörenta staterna
-
National Institute of Allergy and Infectious Diseases...Jacobus Pharmaceutical; Fujisawa Pharmaceutical CoAvslutadHIV-infektioner | Pneumoni, Pneumocystis CariniiFörenta staterna
-
National Institute of Allergy and Infectious Diseases...Fujisawa Pharmaceutical CoAvslutadHIV-infektioner | Pneumoni, Pneumocystis CariniiFörenta staterna, Puerto Rico
-
National Institute of Allergy and Infectious Diseases...AvslutadHIV-infektioner | Pneumoni, Pneumocystis CariniiFörenta staterna, Puerto Rico
-
National Institute of Allergy and Infectious Diseases...AvslutadHIV-infektioner | Pneumoni, Pneumocystis CariniiFörenta staterna, Puerto Rico
-
National Institute of Allergy and Infectious Diseases...Glaxo WellcomeAvslutadHIV-infektioner | Pneumoni, Pneumocystis CariniiFörenta staterna
-
National Institute of Allergy and Infectious Diseases...AvslutadHIV-infektioner | Pneumoni, Pneumocystis CariniiFörenta staterna